Drug
Plenvu
Plenvu: highest development phase Post-Market, developed by Recordati. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Recordati
Trials
| Drug | Phase | Indication |
|---|---|---|
| Plenvu NCT04297423 | Post-Market | Colorectal Cancer |
Latest
No recent events.
Follow Plenvu on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.